BRAXIA SCIENTIFIC CORP. (F:4960) — Market Cap & Net Worth
Market Cap & Net Worth: BRAXIA SCIENTIFIC CORP. (4960)
BRAXIA SCIENTIFIC CORP. (F:4960) has a market capitalization of $566.56K (€484.61K) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #31013 globally and #2729 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BRAXIA SCIENTIFIC CORP.'s stock price €0.00 by its total outstanding shares 283280350 (283.28 Million). Also see 4960 total assets for a full breakdown of the balance sheet.
BRAXIA SCIENTIFIC CORP. Market Cap History: 2020 to 2026
BRAXIA SCIENTIFIC CORP.'s market capitalization history from 2020 to 2026. Data shows change from $192.09 Million to $662.37K (-52.45% CAGR). Also see 4960 cash flow metrics for how efficiently the company converts equity into cash flow.
BRAXIA SCIENTIFIC CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BRAXIA SCIENTIFIC CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BRAXIA SCIENTIFIC CORP. stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.85x
BRAXIA SCIENTIFIC CORP.'s market cap is 1.85 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $17.22 Million | $1.01 Million | -$88.83 Million | 17.08x | N/A |
| 2022 | $6.76 Million | $1.49 Million | -$12.13 Million | 4.54x | N/A |
| 2023 | $3.48 Million | $1.88 Million | -$13.14 Million | 1.85x | N/A |
Competitor Companies of 4960 by Market Capitalization
Companies near BRAXIA SCIENTIFIC CORP. in the global market cap rankings as of September 19, 2026. Review BRAXIA SCIENTIFIC CORP. tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to BRAXIA SCIENTIFIC CORP. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $128.84 Billion | $508.34 |
| #340 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.38 Billion | $784.85 |
| #459 | CSL Ltd | AU:CSL | $60.28 Billion | AU$175.59 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $154.04 |
BRAXIA SCIENTIFIC CORP. Historical Marketcap From 2020 to 2026
Between 2020 and today, BRAXIA SCIENTIFIC CORP.'s market cap moved from $192.09 Million to $ 662.37K, with a yearly change of -52.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €662.37K | 0.00% |
| 2025 | €662.37K | 0.00% |
| 2024 | €662.37K | -80.95% |
| 2023 | €3.48 Million | -48.53% |
| 2022 | €6.76 Million | -60.77% |
| 2021 | €17.22 Million | -91.03% |
| 2020 | €192.09 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of BRAXIA SCIENTIFIC CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $566.56K USD |
| MoneyControl | $566.56K USD |
| MarketWatch | $566.56K USD |
| marketcap.company | $566.56K USD |
| Reuters | $566.56K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BRAXIA SCIENTIFIC CORP.
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more